CD19.20.22 CAR T-cells for Patients With Relapsed/Refractory B-Cell Lymphomas
ENROLLING_BY_INVITATION
Status
Conditions
- B-Cell Lymphoma
- Diffuse Large B Cell Lymphoma (DLBCL)
- Primary Mediastinal Large B-cell Lymphoma (PMBCL)
- Follicular Lymphoma
- Transformed Follicular Lymphoma (tFL)
- Mantle Cell Lymphoma
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Richter Transformation
- Marginal Zone Lymphoma
Interventions
- BIOLOGICAL: CD19.20.22 CAR T cells
- DRUG: Fludarabine and Cyclophosphamide
Sponsor
University of Maryland, Baltimore